Objective-Both HDLs and their major protein constituent apolipoprotein A-I (apoA-I) are transported through aortic endothelial cells. The knock-down of the ATP-binding cassette transporters A1 (ABCA1), G1 (ABCG1), and of the scavenger receptor-BI (SR-BI) diminishes but does not completely block the transport of apoA-I or HDL, so that other receptors appear to be involved. The ectopic ␤-chain of F 0 F 1 ATPase has been previously characterized as an apoA-I receptor, triggering HDL internalization in hepatocytes.
shown to be functional in its unusual location. 18, 19 Components of the F 0 F 1 ATPase, usually the ␤-chain, have been characterized as cell surface receptors for different ligands involved in tumor cell recognition and lysis, intracellular pH homeostasis, angiogenesis, and lipid metabolism. 20 -23 The ␤-chain belongs to the F 1 domain, which contains the binding sites for ATP and ADP as well as the catalytic site for ATP synthesis and hydrolysis. 11 In hepatocytes, it has been characterized as an apoA-I receptor, which triggers HDL endocytosis. 10 Indeed, on binding of apoA-I, F 0 F 1 ATPase hydrolyzes ATP. The ADP thereby produced stimulates hepatic HDL uptake by activating the purinergic receptor P2Y 13 under the control of the small GTPase RhoA and its effector ROCK I. 24, 25 P2Y receptors belong to the family of G-protein coupled receptors and are stimulated by extracellular nucleotides such as ATP, ADP, UTP, as well as UDP. In general they mediate downstream effects of the F 0 F 1 ATPase. In endothelial cells the most prominently expressed P2Y receptors are P2Y 1 , P2Y 2 , P2Y 11 , but also P2Y 4 , P2Y 6 , and P2Y 12 . 26 The ADP-mediated effects in these cells are likely to be mediated by P2Y 1 and by P2Y 12 . 27, 28 In endothelial cells, angiostatin, an endogenous angiogenesis inhibitor, binds to and inhibits cell surface F 0 F 1 ATPase, thus modulating endothelial cell proliferation. 14, 29 Furthermore, it has been shown that apoA-I binds to the F 0 F 1 ATPase expressed on endothelial cells and stimulates proliferation of endothelial cells again by promoting extracellular ADP production. 30 Here we investigated whether cell surface F 0 F 1 ATPase functions as an apoA-I and/or HDL binding protein on the surface of endothelial cells and thereby influences internalization and transendothelial transport of apoA-I and HDL. Furthermore, we investigated the involvement of P2Y receptors in these processes.
Methods

Endothelial Binding, Association, Internalization, and Transport of ApoA-I and HDL
The methods for the isolation and radiolabeling of HDL and apoA-I, the cultivation of bovine aortic endothelial cells as well as the quantification of endothelial binding, association, internalization, and transport of apoA-I and HDL have been described previously 6 -9 as well as in the Supplemental Method section, available online at http://atvb.ahajournals.org.
Pharmacological Treatments and Inhibitors
Endothelial cells were incubated with either the ATP hydrolysis inhibitor IF 1 (Abnova, Taipei, Taiwan) at a final concentration of 100 nmol/L in DMEM Hepes pH 6.4 containing 1% BSA or the pH-independent recombinant IF 1 variant H49K 30 at a concentration of 1 mol/L in DMEM Hepes containing 0.2% BSA, for 30 minutes prior to the assay. To test the involvement of specific P2Y receptors in stimulating endocytosis of HDL, 50 mol/L of the P2Y 1 inhibitor MRS 2179 (M3808, Sigma, Switzerland) or 100 mol/L of the P2Y 12 inhibitor 2-MeSAMP (M1434, Sigma, Switzerland) were added to the cell culture medium 20 minutes prior to the addition of 125 I-HDL. Likewise 1 mol/L ADP (Sigma, Switzerland) or 50 g/mL apoA-I were added to the cells 10 minutes before the addition of 125 I-HDL. All modulators were kept in the medium during the assay.
siRNA Transfection
Endothelial cells were transfected when 80% to 90% confluent. Sixty-seven nmol/L BLOCK-iT TM fluorescent oligo and 100 nmol/L Stealth siRNA (Invitrogen) against ␤-ATPase (GCAGAATC-CCTTCTGCTGTGGGTTA), ABCA1 (GGGACTTAGTGGGAC-GAAATCTCTT), ABCG1 (CGTCCTGCTCTTCTCCG-GATTCTT), SR-BI (TCGTCATGCCCAACATCCTGGTCTT) or not coding siRNA were transfected with Lipofectamine 2000 in OPTIMEM according to the manufacturer's protocol. Six hours after transfection, the medium was replaced by DMEM 5% FCS. Binding, cell association and transport assays were conducted 2 to 3 days after transfection. The efficiency of the silencing was evaluated by quantitative RT-PCR and western blotting.
Quantitative RT-PCR
RNA was isolated with RNeasy mini (Qiagen) according to the manufacturer's protocol. Reverse transcription was performed with Superscript II RT (Invitrogen) following the standard procedure. Quantitative PCR was done with LightCycler FastStart DNA Master SYBR Green I (Roche). Beta-ATPase (GGTAGCGCTGGTG-TACGGTC, CGGGACA ACACAGTGGTAGC, 64°C, 3 mmol/L MgCl 2 ) transcription levels were normalized to GAPDH (GTCTTCACTACCATGGAGAAGG, TCATGGATGAC CTTG-GCCAG, 58°C, 4 mmol/L MgCl 2 ). Conventional PCR was carried out using following primers: P2Y 1 (GGTCCCCAACGGGACG-GACA, CAGCGCGCATTTGAACGGGC, 60°C, 1.5 mmol/L MgCl 2 ), P2Y 12 (ATTTTGCCCGAATTCCCTAC, ATCCAGGCAT-GCATTTAAGG, 53°C, 2 mmol/L MgCl 2 ).
Cell Surface Biotinylation
Cell monolayers were biotinylated with 250 g/mL EZ-link-sulfo-NHS-LC-biotin (Pierce) in PBS containing 0.1 mmol/L CaCl 2 and 1 mmol/L MgCl 2 at 4°C for 1 hour. The reaction was terminated by 5 minutes incubation in DMEM. Cells were lysed in RIPA buffer (10 mmol/L Tris pH 7.4, 150 mmol/L NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, proteases inhibitor complete EDTA [Roche]). The lysates were incubated with 25 L streptavidinconjugated sepharose beads (Amersham Biosciences) at 4°C overnight. The beads were washed 3 times with the lysis buffer and the pulled-down proteins were resolved on a SDS-PAGE. Ten micrograms total proteins from the supernatant and 60 g total proteins of the beads were loaded on the SDS-PAGE.
Western Blotting
Endothelial cells were lysed in RIPA buffer. Proteins were separated on a SDS-PAGE and transblotted onto a PVDF membrane (GE Healthcare). The expression of ␤-ATPase was analyzed by Western blotting using the anti-␤-ATPase antibody MS503 from MitoSciences (Eugene, OR) in comparison to the expression of actin (antiactin AC-15, Sigma) or GAPDH (anti-GAPDH ab9484, Abcam, Cambridge, MA).The expression of P2Y receptors was analyzed using the anti-P2Y 1 antibody (A-15) sc-15204 from Santa Cruz Biotechnology and the anti-P2Y 12 antibody ab82725 from Abcam (Cambridge, MA).
Determination of Extracellular and Intracellular ATP Concentrations
Extracellular and intracellular ATP concentrations were measured by luciferase driven bioluminescence (ATP bioluminescence assay kit HSII, Roche). Cells were rinsed twice in DMEM prior incubation in DMEM Hepes 1% BSA with or without 5 g/mL apoA-I. After 30 minutes incubation, the assay medium was collected to measure the extracellular ATP concentration and the cells were lysed in the provided lysis buffer to determine intracellular ATP concentration. As positive control, intracellular ATP concentrations were measured after inhibition of the mitochondrial ATP synthesis with 5 mol/L rotenone for 60 minutes.
Statistical Analyses
The data for all experiments were analyzed using GraphPad Prism 5 software program. Comparisons between groups were performed using t-test methods. Experiments were routinely performed in triplicates or quadruplets. Each experiment shown is a representative of at least 3 similar experiments. If not indicated otherwise the data are graphically represented as meansϮSD, *PϽ0.05, **PϽ0.01, ***PϽ0.001, ns, not significantly different compared to control cells (ANOVA).
Results
Cell Surface Expression of ␤-ATPase and Role of ␤-ATPase in ApoA-I Binding
At first, the presence of the ␤-chain of the F 0 F 1 ATPase (␤-ATPase) on the surface of endothelial cells was verified by cell surface biotinylation and streptavidin pull-down ( Figure 1A ). Beta-ATPase could be pulled down using streptavidin beads, only if the cell surface was biotinylated. By contrast, the intracellular protein GAPDH was not captured by streptavidin, which indicates that the mitochondrial complex was not unspecifically biotinylated. Thus, we confirmed that the ␤-ATPase is expressed on the surface of endothelial cells. The role of ␤-ATPase as a binding partner for apoA-I on the surface of endothelial cells was assessed after reducing its expression by RNA interference. Thereby, ␤-ATPase expression was diminished by 90% on the RNA level and by about 50% on the protein level ( Figure 1B and 1C). The energetic status of the cells after reducing the expression of ␤-ATPase was evaluated by measuring intracellular ATP levels. Intracellular ATP concentration remained unchanged after ␤-ATPase knock-down ( Figure 1D ). In contrast, apoA-I binding at 4°C was diminished by 50% after silencing ␤-ATPase ( Figure 1E ), whereas the HDL binding was not affected by silencing of ␤-ATPase ( Figure  1F ). Furthermore, cells were treated with IF 1 , which binds to ␤-ATPase and inhibits ATP hydrolysis. 31,32 IF 1 inhibited apoA-I binding by about 55% but had no effect on the binding of HDL ( Figure 1G ). These results indicate that cell surface ␤-ATPase modulates the binding of apoA-I but not HDL to endothelial cells.
Role of F 0 F 1 ATPase in ApoA-I and HDL Cell Association and Transendothelial Transport
The ATPase inhibitor IF 1 was used to evaluate the implication of F 0 F 1 ATPase in cell association, internalization and transport of initially lipid-free apoA-I or HDL. In the presence of IF 1 , the cellular association (Figure 2A ), internalization (data not shown), and transcellular transport ( Figure 2C ) of initially lipid-free apoA-I were diminished by about 30%, 60%, and 50%, respectively. Similar results were obtained by siRNA interference with ␤-ATPase, namely a 50% decrease in apoA-I internalization and an 80% decrease in apoA-I transport (Supplemental Figure I) . Both the specific association and the transport of HDL transport were diminished by about 50% in the presence of IF 1 (Figure 2B and 2D) . Taken together, these results suggest that cell surface F 0 F 1 ATPase modulates the cell association and transendothelial transport of both initially lipid-free apoA-I and HDL.
Activity of Cell Surface F 0 F 1 ATPase
To assess the impact of apoA-I on the activity of cell surface F 0 F 1 ATPase, extracellular ATP concentrations were measured in the presence and in the absence of apoA-I and after ␤-ATPase knock-down ( Figure 3A) . First, preincubation of nontransfected cells with apoA-I for 30 minutes reduced the extracellular ATP concentration by 50% indicating that apoA-I stimulated the extracellular hydrolysis of ATP. Moreover, in the absence of apoA-I, ATP accumulated extracellularly when ␤-ATPase was silenced, suggesting that F 0 F 1 ATPase hydrolyzes ATP on the surface of endothelial cells. Finally, the extracellular ATP concentration was reduced only by about 10% in the presence of apoA-I after ␤-ATPase silencing. These data reveal that on the surface of endothelial cells, F 0 F 1 ATPase hydrolyzes ATP in an apoA-I induced manner.
Effect of ApoA-I and Extracellular ADP on HDL Internalization
We next investigated whether the endocytosis of HDL depends on the ADP produced by F 0 F 1 ATPase or on apoA-I itself. HDL binding was increased by about 50% in the presence of either 1 mol/L ADP or 50 g/mL apoA-I ( Figure 3B ). The cellular association of HDL was enhanced by about 30% and 50% in the presence of ADP and apoA-I, respectively ( Figure 3C ). The internalization of HDL was augmented by 35% and 25% by stimulation with ADP and apoA-I, respectively ( Figure 3D ). Also the internalization of initially lipid-free apoA-I was stimulated by ATP and ADP, namely by 20% and 50%, respectively (Supplemental Figure  IIA) . In addition, 2MeS-ADP (ie, a nonhydrolysable form of ADP) but not ATP-␥S (ie, a nonhydrolysable form of ATP) stimulated apoA-I uptake by 60% (Supplemental Figure IIB and IIC). These data hence indicate that ADP generated by ATPase on stimulation through apoA-I stimulates the internalization of both initially lipid-free apoA-I and HDL by endothelial cells.
Role of P2Y Receptors in HDL Endocytosis
We next tried to identify the P2Y receptor through which ADP stimulates the endocytosis of HDL. First we confirmed the expression of the purinergic receptors P2Y 1 and P2Y 12 in bovine aortic endothelial cells both on the mRNA ( Figure  4A ) and protein level ( Figure 4B ). The cell association of HDL was reduced by about 40% in the presence of the P2Y 12 inhibitor 2-MeSAMP and not at all in the presence of the P2Y 1 inhibitor MRS 2179 ( Figure 4C ). Furthermore, the ADP-induced increase in HDL cell association was prevented by the P2Y 12 inhibitor 2-MeSAMP, but not by the P2Y 1 inhibitor MRS 2179 ( Figure 4D ). These data indicate that ADP stimulates the endocytosis of HDL into endothelial cells by activation of the P2Y 12 receptor. 
Interaction of ␤-ATPase With Other ApoA-I and HDL Endocytosis Modulators
Finally, we investigated possible interactions of the ␤-ATPase with ABCA1, ABCG1, or SR-BI, which were previously shown by us to modulate the transendothelial transport of apoA-I or HDL. 7, 8 To this end we incubated bovine aortic cells with specific siRNAs against these transporters or receptors either alone or in combination with the ATP hydrolysis inhibitor IF 1 . As shown previously, 7,8 the specific siRNAs reduced ABCA1, ABCG1, and SR-BI ex-pression by about 80% to 90% on the mRNA level and by approximately 50% on the protein level as assessed by quantitative RT-PCR and Western blotting, respectively. The cell association of apoA-I was reduced by about 45% through silencing of ABCA1, by about 30% through inhibition of ␤-ATPase with IF 1 , and by 40% through joint inhibition of both targets together ( Figure 5A) . The specific transendothelial transport of apoA-I was reduced by 80%, 45%, and 55% by inhibition of ABCA1, ␤-ATPase, and both, respectively ( Figure 5B ). The cell association of HDL was reduced by about 40% and 30%, when ABCG1 and SR-BI, respectively, were silenced, and by 45% when ␤-ATPase was inhibited with IF 1 . Coinhibition of ABCG1 and ␤-ATPase as well as coinhibition of SR-BI and ␤-ATPase diminished the endothelial cell association of HDL by about 30% (Figure 5C ).
Discussion
We have previously demonstrated that endothelial cells bind, internalize, and transcytose apoA-I and HDL in a saturable and temperature-dependent manner. 6 By siRNA interference we also showed that ABCA1 modulates the transendothelial transport of apoA-I, 7 whereas ABCG1 and SR-BI modulate the transport of HDL. 8 In addition, we showed that the transendothelial apoA-I transport is a 2-step process in which apoA-I is initially lipidated by ABCA1 and then further processed by ABCA1-independent mechanisms, most likely involving ABCG1 and SR-BI. 9 In the present study, we provide strong biochemical evidence that apoA-I stimulates the transport of initially lipid-free apoA-I and HDL across endothelial cells by inducing ectopic cell surface F 0 F 1 ATPase to generate extracellular ADP, which then stimulates the endocytosis of HDL or lipidated apoA-I by activating the purinergic receptor P2Y 12 (Figure 6 ). F 0 F 1 ATPase is the principal ATP synthesis complex in mitochondria. It consists of a catalytic domain F 1 and a transmembrane domain F 0 . The ␤-chain belongs to the F 1 domain and was shown by various laboratories to be ectopically expressed in the plasma membrane of various cell types including endothelial cells and hepatocytes. 10, 14, 30 In hepatocytes, adipocytes, and endothelial cells, F 0 F 1 ATPase has been characterized as an apoA-I receptor that triggers the internalization of HDL 10 , recycling of apoA-I, 30 and antiapoptotic and proproliferative effects of HDL. 30 We here confirmed that ␤-ATPase is expressed in the plasma membrane of endothelial cells by biotinylation of the cell surface and streptavidin pull-down ( Figure 1A) . Reducing the endothelial expression of ␤-ATPase by siRNA interference or inhibiting ATP hydrolysis by IF 1 , which binds the F 1 domain of F 0 F 1 ATPase, significantly diminished the 4°C binding of apoA-I ( Figure 1E and 1G) but not HDL to endothelial cells ( Figure  1F and 1G) . These results suggest that F 0 F 1 ATPase binds lipid-free apoA-I but not mature HDL particles. In contrast, at 37°C the cell association and the transport of both apoA-I and HDL were diminished by the F 0 F 1 ATPase inhibitor IF 1 (Figure 2 ). These at first sight controversial findings between the binding and association experiments at 4°C and 37°C are compatible with a model proposed by Martinez and colleagues who suggested that apoA-I binding to ectopic ␤-ATPase triggers the internalization of HDL by a down- stream receptor. 10 In line with observations and conclusions of Howard and colleagues made in experiments with adipocytes, 33 our findings suggest that in addition to mature HDL also lipid-free apoA-I can be internalized by this pathway. However, based on our previously reported findings that initially lipid-free apoA-I is lipidated by ABCA1 for subsequent ABCA1-independent internalization and transport, we assume that a nascent lipidated apoA-I particle rather than lipid-free apoA-I is the substrate for ␤-ATPase triggered endocytosis. Also the nonadditive effects of ABCA1 interference and ␤-ATPase inhibition on the endothelial association and transport of apoA-I ( Figure 5A and 5B) are in agreement with this model.
Similarly to mitochondrial F 0 F 1 ATPase, cell surface F 0 F 1 ATPase has been shown to catalyze both ATP synthesis 15, 29 and ATP hydrolysis. 10,34 F 0 F 1 ATPase was originally thought to catalyze extracellular ATP synthesis. 29 In the present study, the activity of cell surface F 0 F 1 ATPase was evaluated after ␤-ATPase silencing, in the presence and in the absence of apoA-I ( Figure 3A ). Thereby we confirmed previous findings of Martinez and colleagues that binding of apoA-I to ectopic F 0 F 1 ATPase of either hepatocytes or endothelial cells triggers the hydrolysis of ATP. This suggests that like in hepatocytes, 10 the apoA-I induced hydrolysis of ATP triggers the uptake of HDL into endothelial cells. In agreement with this interpretation binding, cell association and internalization of HDL were increased in the presence of extracellular ADP and apoA-I ( Figure 3B-3D ). The internalization of initially lipid-free apoA-I was also increased in the presence of extracellular ATP and, even more, ADP (Supplemental Figure IIA) . In addition, 2MeS-ADP (a nonhydrolysable form of ADP) but not ATP-␥S (a nonhydrolysable form of ATP) were found to stimulate the uptake of initially lipid-free apoA-I into endothelial cells (Supplemental Figure IIB and IIC) .
However, as discussed before, we assume that during the incubation with cells, the initially lipid-free apoA-I was lipidated by ABCA1 so that we likely recorded the stimulated uptake of a nascent HDL particle rather than lipid-free apoA-I.
In hepatocytes, the G-protein coupled purinergic receptor P2Y 13 has been identified as the immediate downstream target of dinucleotides that are generated by F 0 F 1 ATPase on binding of apoA-I. By using specific agonists, Martinez and colleagues generated evidence that P2Y 13 then signals to a further downstream endocytic HDL receptor that has not yet been identified. 35 Furthermore and pointing to the physiological relevance of Martinez et al's in vitro findings, P2Y 13deficient mice show a decrease in hepatic HDL cholesterol uptake, hepatic cholesterol content, and biliary cholesterol output, although their plasma HDL and other lipid levels were normal. 36 Endothelial cells express at least 6 P2Y receptors that modulate vascular permeability. 37, 38 However neither is P2Y 13 among them nor is any of them stimulated by the specific P2Y 13 receptor agonist. Among the known endothelial P2Y receptors, only P2Y 1 and P2Y 12 are, like P2Y 13, stimulated by ADP. 39 Therefore, we tested the effects of the P2Y 1 inhibitor MRS 2179 and the P2Y 12 inhibitor 2-MeSAMP on the cell association of HDL. Two-MeSAMP but not MRS 2179 inhibited both unstimulated ( Figure 4C ) and ADP-stimulated association of HDL with endothelial cells (Figure 4D ) indicating the involvement of P2Y 12 rather than P2Y 1 in the endothelial uptake of HDL. Interestingly, P2Y 12 and P2Y 13 , which stimulate endothelial and hepatic endocytosis of HDL, respectively, share a high degree of sequence homology and couple both to members of the G i family of G proteins, 40 whereas P2Y 1 principally uses the G q/11 G protein subunit. In addition to the activation of the phosphatidylinositol 3-kinase via G i , P2Y 12 has also been Figure 6. Model of transendothelial transport of apoA-I and HDL. By lipidating apolipoprotein A-I (apoA-I) ABCA1 generates a particle that is processed by a mechanism which, like the transport of mature HDL, involves ABCG1 and SR-BI. The F 0 F 1 ATPase hydrolyzes ATP on binding of apoA-I. The produced ADP binds to P2Y 12 and stimulates the internalization and transendothelial transport of lipidated apoA-I and HDL via the activation of G proteins.
shown to activate RhoA and Rho kinase 41 leading to actin cytoskeleton reorganization. Future work will have to unravel the downstream signaling cascade of the endothelial P2Y 12 receptor, which ultimately leads to endothelial uptake of HDL.
Previously we found that the endothelial binding, uptake, and transport of apoA-I and HDL are modulated by ABCA1, ABCG1, and SR-BI. [7] [8] [9] Our novel findings raise the question whether they interact with ectopic ␤-ATPase. Our coinhibition experiments did not find any additive effects suggesting that ABCA1, ABCG1, SR-BI, and F 0 F 1 ATPase interact in a series of events rather than on independent parallel processes. For example, in the context of our previous findings, we suggest that ABCA1 generates a lipidated apoA-I particle as the substrate for an endocytic pathway, which is triggered via the ␤-ATPase-ADP-P2Y 12 -axis. In this regard it is interesting to note that ␤-ATPase was previously shown to modulate the internalization and resecretion of apoA-I by adipocytes without affecting phospholipid and cholesterol efflux. 33 The interaction of ABCG1, SR-BI, and the ␤-ATPase-ADP-P2Y 12 -axis is even more elusive. Figure 6 summarizes our current model of transendothelial transport of apoA-I and HDL: By lipidating apoA-I, ABCA1 generates a particle that is then processed by ABCA1-independent mechanisms for transendothelial transport. 9 Like the transport of mature HDL, the processing of these nascent HDL particles appears to involve ABCG1 and SR-BI. In parallel binding of apoA-I to cell surface F 0 F 1 ATPase stimulates the hydrolysis of ATP. The ADP thereby produced binds to the P2Y 12 receptor of endothelial cells and stimulates the internalization of and hence transendothelial transport of nascent and mature HDL via activation of G proteins.
To conclude, the present study demonstrates that on the surface of endothelial cells the F 0 F 1 ATPase hydrolyzes ATP on binding of apoA-I. The ADP thereby produced stimulates apoA-I and HDL internalization and transendothelial transport of initially lipid-free apoA-I and HDL via activation of the P2Y 12 receptor. Future research will have to characterize the thereby elicited signaling events as well as their downstream targets mediating the endothelial endocytosis of HDL.
